Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toni K Choueiri

Showing results (1-10 of 837) with videos related to

Pageof 84
Sort By:
Hematology/Oncology Clinics of North America|July 19, 2011
Renal cell carcinomaToni K Choueiri
Current Opinion in Investigational Drugs (London, England : 2000)|June 3, 2008
Axitinib, a novel anti-angiogenic drug with promising activity in various solid tumorsToni K Choueiri
Journal of the National Comprehensive Cancer Network : JNCCN|May 25, 2013
Clinical treatment decisions for advanced renal cell cancerToni K Choueiri
Clinical Genitourinary Cancer|May 27, 2008
Factors associated with outcome in patients with advanced renal cell carcinoma in the era of antiangiogenic agentsToni K Choueiri
Clinical Advances in Hematology & Oncology : H&O|April 14, 2010
Prognostic factors in patients treated with VEGF-targeted therapiesToni K Choueiri
Current Clinical Pharmacology|August 11, 2011
VEGF inhibitors in metastatic renal cell carcinoma: current therapies and future perspectiveToni K Choueiri
Urologic Oncology|November 19, 2013
Precision medicine for metastatic renal cell carcinomaGuru Sonpavde, Toni K Choueiri
Nature Medicine|May 15, 2020
IL-8 and cancer prognosis on immunotherapyZiad Bakouny, Toni K Choueiri
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 22, 2026
From Anatomy to Theranostics: Toni Choueiri Talks with Ken Herrmann About the Evolution of Genitourinary OncologyToni K Choueiri, Ken Herrmann
The Lancet. Oncology|July 21, 2009
Sunitinib in renal-cell carcinoma: expanded indicationsToni K Choueiri, Joaquim Bellmunt
Pageof 84

Showing results (1-10 of 837) with videos related to

Sort By:
Pageof 84
Hematology/Oncology Clinics of North America|July 19, 2011
Renal cell carcinomaToni K Choueiri
Current Opinion in Investigational Drugs (London, England : 2000)|June 3, 2008
Axitinib, a novel anti-angiogenic drug with promising activity in various solid tumorsToni K Choueiri
Journal of the National Comprehensive Cancer Network : JNCCN|May 25, 2013
Clinical treatment decisions for advanced renal cell cancerToni K Choueiri
Clinical Genitourinary Cancer|May 27, 2008
Factors associated with outcome in patients with advanced renal cell carcinoma in the era of antiangiogenic agentsToni K Choueiri
Clinical Advances in Hematology & Oncology : H&O|April 14, 2010
Prognostic factors in patients treated with VEGF-targeted therapiesToni K Choueiri
Current Clinical Pharmacology|August 11, 2011
VEGF inhibitors in metastatic renal cell carcinoma: current therapies and future perspectiveToni K Choueiri
Urologic Oncology|November 19, 2013
Precision medicine for metastatic renal cell carcinomaGuru Sonpavde, Toni K Choueiri
Nature Medicine|May 15, 2020
IL-8 and cancer prognosis on immunotherapyZiad Bakouny, Toni K Choueiri
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 22, 2026
From Anatomy to Theranostics: Toni Choueiri Talks with Ken Herrmann About the Evolution of Genitourinary OncologyToni K Choueiri, Ken Herrmann
The Lancet. Oncology|July 21, 2009
Sunitinib in renal-cell carcinoma: expanded indicationsToni K Choueiri, Joaquim Bellmunt
Pageof 84